Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Cancer Cachexia Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global cancer cachexia market reached a value of US$ 1.88 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 2.53 Billion by 2027, exhibiting a CAGR of 4.80% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor. 

Cancer cachexia refers to a multifactorial, host-phagocytic, wasting syndrome that is characterized by systematic inflammation, involuntary loss of lean body mass, negative protein balance, loss of appetite and muscle atrophy. It is caused due to the occurrence of various chronic diseases, including tuberculosis (TB), multiple sclerosis, chronic obstructive pulmonary disease (COPD) and human immunodeficiency virus (HIV). Cancer cachexia can be treated with the utilization of various therapeutics, such as progestogen, corticosteroid, and combination therapy. Amongst these, a progestogen is a synthetic or natural steroid hormone that improves appetite and promotes weight gain, whereas corticosteroid assists in mitigating inflammation and suppressing overactive immune systems. 

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

Cancer Cachexia Market Trends:

The increasing prevalence of cancer and cachexia, especially amongst the rising geriatric populations, is facilitating the demand for advanced therapeutic treatment and drugs, which in turn, is primarily driving the market growth. This is further supported by the increasing awareness amongst consumers regarding the availability of novel therapeutic drugs to treat cancer cachexia. Additionally, the shifting inclination of patients toward combinational therapies for improving lean body mass (LBM) through pharmacological, non-pharmacological therapies and clinical trials is acting as another growth-inducing factor. In line with this, the extensive utilization of several appetite stimulants, such as megestrol acetate, dexamethasone, and methylprednisolone, for improving digestion is also contributing to the market growth. Moreover, significant technological advancements that are emphasizing on the development of effective medicines for cancer cachexia treatment are further propelling the market growth. Apart from this, the numerous favorable initiatives being undertaken by the government bodies of various countries and non-governmental organizations (NGOs) for sensitizing people regarding the causes of cancer cachexia, their symptoms and benefits of using advanced treatments are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cancer cachexia market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on therapeutics, mode of action and distribution channel.

Breakup by Therapeutics:

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • Progestogens
  • Corticosteroids
  • Combination Therapy
  • Others
     

Breakup by Mode of Action:

  • Appetite Stimulators
  • Weight Loss Stabilizers
     

Breakup by Distribution Channel:

  • Hospital Stores
  • Retail Pharmacy
  • Online Pharmacy
     

Breakup by Region:

 

 
 

www.imarcgroup.com

To get more information on the regional analysis of this market, Request Sample

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AAVogen Inc., Actimed Therapeutics Ltd., Aphios Corporation, Artelo Biosciences Inc., AVEO Pharmaceuticals Inc., Fresenius Kabi AG (Fresenius SE & Co. KGaA), Helsinn Healthcare SA, Merck & Co. Inc., NGM Biopharmaceuticals Inc., Pfizer Inc. and Tetra Bio-Pharma.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Therapeutics, Mode of Action, Distribution Channel, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered AAVogen Inc., Actimed Therapeutics Ltd., Aphios Corporation, Artelo Biosciences Inc., AVEO Pharmaceuticals Inc., Fresenius Kabi AG (Fresenius SE & Co. KGaA), Helsinn Healthcare SA, Merck & Co. Inc., NGM Biopharmaceuticals Inc., Pfizer Inc. and Tetra Bio-Pharma.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global cancer cachexia market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global cancer cachexia market?
  • What are the key regional markets?
  • What is the breakup of the market based on the therapeutics?
  • What is the breakup of the market based on the mode of action?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global cancer cachexia market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction
    4.1    Overview
    4.2    Key Industry Trends
5    Global Cancer Cachexia Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Therapeutics
    6.1    Progestogens
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Corticosteroids
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Combination Therapy
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Others
        6.4.1 Market Trends
        6.4.2 Market Forecast
7    Market Breakup by Mode of Action
    7.1    Appetite Stimulators
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Weight Loss Stabilizers
        7.2.1 Market Trends
        7.2.2 Market Forecast
8    Market Breakup by Distribution Channel
    8.1    Hospital Stores
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Retail Pharmacy
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Online Pharmacy
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis
    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape
    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    AAVogen Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
        14.3.2    Actimed Therapeutics Ltd.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
        14.3.3    Aphios Corporation
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
        14.3.4    Artelo Biosciences Inc.
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
        14.3.5    AVEO Pharmaceuticals Inc.
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    Fresenius Kabi AG (Fresenius SE & Co. KGaA)
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 SWOT Analysis
        14.3.7    Helsinn Healthcare SA
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
        14.3.8    Merck & Co. Inc.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
           14.3.8.4 SWOT Analysis
        14.3.9    NGM Biopharmaceuticals Inc.
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
        14.3.10    Pfizer Inc.
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis
        14.3.11    Tetra Bio-Pharma
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 Financials

List of Figures

Figure 1: Global: Cancer Cachexia Market: Major Drivers and Challenges
Figure 2: Global: Cancer Cachexia Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Cancer Cachexia Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Cancer Cachexia Market: Breakup by Therapeutics (in %), 2021
Figure 5: Global: Cancer Cachexia Market: Breakup by Mode of Action (in %), 2021
Figure 6: Global: Cancer Cachexia Market: Breakup by Distribution Channel (in %), 2021
Figure 7: Global: Cancer Cachexia Market: Breakup by Region (in %), 2021
Figure 8: Global: Cancer Cachexia (Progestogens) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Cancer Cachexia (Progestogens) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Cancer Cachexia (Corticosteroids) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Cancer Cachexia (Corticosteroids) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Cancer Cachexia (Combination Therapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Cancer Cachexia (Combination Therapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Cancer Cachexia (Other Therapeutics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Cancer Cachexia (Other Therapeutics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Cancer Cachexia (Appetite Stimulators) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Cancer Cachexia (Appetite Stimulators) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Cancer Cachexia (Weight Loss Stabilizers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Cancer Cachexia (Weight Loss Stabilizers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Cancer Cachexia (Hospital Stores) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Cancer Cachexia (Hospital Stores) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Cancer Cachexia (Retail Pharmacy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Cancer Cachexia (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Cancer Cachexia (Online Pharmacy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Cancer Cachexia (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: North America: Cancer Cachexia Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: North America: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: United States: Cancer Cachexia Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: United States: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Canada: Cancer Cachexia Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Canada: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Asia-Pacific: Cancer Cachexia Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Asia-Pacific: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: China: Cancer Cachexia Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: China: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Japan: Cancer Cachexia Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Japan: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: India: Cancer Cachexia Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: India: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: South Korea: Cancer Cachexia Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: South Korea: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Australia: Cancer Cachexia Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Australia: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Indonesia: Cancer Cachexia Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Indonesia: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Others: Cancer Cachexia Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Others: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Europe: Cancer Cachexia Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Europe: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Germany: Cancer Cachexia Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Germany: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: France: Cancer Cachexia Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: France: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: United Kingdom: Cancer Cachexia Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: United Kingdom: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Italy: Cancer Cachexia Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Italy: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Spain: Cancer Cachexia Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Spain: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Russia: Cancer Cachexia Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Russia: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Others: Cancer Cachexia Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Others: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Latin America: Cancer Cachexia Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Latin America: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Brazil: Cancer Cachexia Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Brazil: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Mexico: Cancer Cachexia Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Mexico: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Others: Cancer Cachexia Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Others: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Middle East and Africa: Cancer Cachexia Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Middle East and Africa: Cancer Cachexia Market: Breakup by Country (in %), 2021
Figure 74: Middle East and Africa: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Global: Cancer Cachexia Industry: SWOT Analysis
Figure 76: Global: Cancer Cachexia Industry: Value Chain Analysis
Figure 77: Global: Cancer Cachexia Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Cancer Cachexia Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Cancer Cachexia Market Forecast: Breakup by Therapeutics (in Million US$), 2022-2027
Table 3: Global: Cancer Cachexia Market Forecast: Breakup by Mode of Action (in Million US$), 2022-2027
Table 4: Global: Cancer Cachexia Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 5: Global: Cancer Cachexia Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Cancer Cachexia Market: Competitive Structure
Table 7: Global: Cancer Cachexia Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links